This listing may be outdated. Verify details at the official source before applying.

ActiveWashington University in St. Louis, Center for Pediatric Immunology · 2026

Discovery Awards

Quick Facts

Agency: Washington University in St. Louis, Center for Pediatric Immunology
Funding: Up to $75,000
Deadline: Check Source
Status: Active
Eligibility: Full members (instructors, assistant or associate professors as well as clinical trainees (residents and fellows) based at St. Louis Children's Hospital).

About This Grant

Discovery Awards is sponsored by Washington University in St. Louis, Center for Pediatric Immunology. Aims to advance the discovery, diagnosis, and treatment for children with inborn errors of immunity.

This may include developing model systems and new scientific directions for investigators.

View Original RFP

Get a weekly digest of new grants like this

A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.

Or search similar grants →

Eligibility Requirements

Full members (instructors, assistant or associate professors as well as clinical trainees (residents and fellows) based at St. Louis Children's Hospital).

Frequently Asked Questions

Who can apply for Discovery Awards?

According to the current listing, eligibility includes: Full members (instructors, assistant or associate professors as well as clinical trainees (residents and fellows) based at St. Louis Children's Hospital). Confirm the full requirements in the official notice before applying.

How much funding does Discovery Awards offer?

The current listing shows up to $75,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.

Who funds Discovery Awards?

Discovery Awards is funded by Washington University in St. Louis, Center for Pediatric Immunology. Verify program details on the funder's official page before applying.

How do I apply for Discovery Awards?

Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.

Funder Profile

Ready to start your proposal?

Granted drafts, reviews, and strengthens your grant application — saving weeks of work. Professional members win a grant in 12 months or get a full refund.

Browse More Grants

Backed by the Granted Guarantee

Similar Grants from Other Funders

Dept. of the Army -- USAMRAA

Grants.govDeadline PassedBetween cycles — Between funding cycles - the FY26 required pre-application (LO…

DoW Duchenne Muscular Dystrophy, Idea Development Award

Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports impactful, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with Duchenne muscular dystrophy (DMD) in the near term. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale. The DMDRP strongly encourages research projects investigating therapies designed to demonstrate efficacy cross the life span, including infants, toddlers and nonambulatory individuals.Distinctive Features: The FY26 DMDRP IDA mechanism offers three eligibility career categories:• The Established Investigator category is for independent investigators at all academic levels, or equivalent• The New Investigator – Early-Stage category is for independent investigators early in their careers (i.e., within 10 years of their first faculty appointment or equivalent). Applicants in this category will be reviewed separately from Established Investigators.• The New Investigator – Transitioning category is for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy who are seeking to transition to a career in DMD, thereby bringing their expertise to the field. Applicants in this category will be reviewed separately from Established Investigators.Preliminary data relevant to DMD that supports the feasibility of the research hypotheses and research approaches are required for all applications. Clinical trials or clinical trial aims are not allowed. Funding Opportunity Number: HT942526DMDRPIDA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $2.5M total program funding.

Up to $500,000 total costs per award (2-year maximum)Deadline: Sep 4, 2026 (passed)

Washington University in St. Louis, Center for Pediatric Immunology Grant Writing Tips

The Gates Foundation Just Wrote a $540 Million, 10-Year Check. The Interesting Number Is 60 Percent.

Gates committed $540.2 million over a decade to the Institute for Health Metrics and Evaluation — the largest gift in University of Washington history — while IHME's federal grant income falls from $7.3 million to a projected $4.8 million. The gift is a case study in the anchor-funder model: what it can do that federal money cannot, and the concentration risk it quietly underwrites.

Read article

The Word "Bridge Grant" Changed Meaning This Year. Some of Them Now Pay You to Decide Whether to Close.

Meyer pulled $6.5 million from a $200 million endowment. Greater Washington has deployed $14.3 million and put more than $1 million into Bridge Grants for 21 organizations — explicitly including mergers and organizational sunsets. Boston is funding merger facilitation. Here is how to tell which product an RFP is offering, and how to apply for the one you actually want.

Read article

DOE's ASPECT Solicitation Is Out — and the Award Range Starts at Zero

The full ASPECT NOFO (DE-FOA-0003647) posted September 4, 2026, eleven days later than the Notice of Intent predicted. The real document splits $58 million across two topic areas with anticipated award counts of 0-7 and 0-3, a cost share that jumps from 20 percent to 50 percent mid-project, a mandatory five-page concept paper due October 9, and a university eligibility restriction that decides team structure before anyone writes a word.

Read article